Opaleye Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
|
|||||
|
2025
Q1 | $7.37M | Sell |
|
|||||
|
2024
Q4 | $9.64M | Buy |
|
|||||
|
2024
Q3 | $3.08M | Sell |
|
|||||
|
2024
Q2 | $5.3M | Sell |
|
|||||
|
2024
Q1 | $10.8M | Hold |
|
|||||
|
2023
Q4 | $5.05M | Hold |
|
|||||
|
2023
Q3 | $4.5M | Hold |
|
|||||
|
2023
Q2 | $6.44M | Hold |
|
|||||
|
2023
Q1 | $8.08M | Hold |
|
|||||
|
2022
Q4 | $7.22M | Sell |
|
|||||
|
2022
Q3 | $7.99M | Buy |
|
|||||
|
2022
Q2 | $8.88M | Buy |
|
|||||
|
2022
Q1 | $13.7M | Buy |
|
|||||
|
2021
Q4 | $18M | Buy |
|
|||||
|
2021
Q3 | $17.7M | Hold |
|
|||||
|
2021
Q2 | $24.9M | Hold |
|
|||||
|
2021
Q1 | $40.3M | Hold |
|
|||||
|
2020
Q4 | $61.9M | Hold |
|
|||||
|
2020
Q3 | $43.1M | Buy |
|
|||||
|
2020
Q2 | $64.8M | Hold |
|
|||||
|
2020
Q1 | $52.1M | Buy |
|
|||||
|
2019
Q4 | $75K | Buy |
|
|||||
|
2019
Q3 | $14K | Buy |
|